Leili Mohebnasab: Understanding Placental Health Through Epigenetics
Leili Mohebnasab, Midwife at Shariati Hospital, shared a post on LinkedIn:
“Epigenetic Biomarkers of Placental Health:
What DNA Methylation Reveals—and Where It Must Remain Silent
For decades, placental health has been assessed indirectly—through fetal growth patterns, Doppler findings, and late clinical syndromes such as preeclampsia or preterm birth. These approaches detect outcomes, not the biological processes unfolding earlier in pregnancy.
Epigenetics offers a different perspective.
According to guidance and research priorities from the World Health Organization, NIH-supported placental biology programs, and CDC population health frameworks (2020–2025), epigenetic markers—particularly DNA methylation (DNAm)—reflect how the placenta adapts to its environment over time.
The placenta is epigenetically dynamic
Placental tissue undergoes rapid differentiation, immune modulation, and metabolic adaptation. NIH research shows that DNAm patterns shift predictably across gestation as part of normal development. These changes are not signs of damage—they are features of placental biology.
When timing appears altered
In some complicated pregnancies, placental DNAm patterns suggest biological ‘age acceleration,’ meaning the placenta appears epigenetically older than expected for gestational age. WHO emphasizes that this reflects cumulative biological stress—not inevitable pathology or outcome.
What epigenetic biomarkers can tell us
At the population level, altered DNAm patterns have been associated with placental insufficiency, fetal growth restriction, and hypertensive disorders of pregnancy. These associations deepen biological understanding but do not provide individual prediction.
What they cannot do
Global guidance is clear:
- epigenetic markers are not screening tools,
- they do not establish causality,
- they do not justify intervention in asymptomatic pregnancy.
A clinical and midwifery perspective
Epigenetic research reframes how we understand placental adaptation—but it does not change the foundations of care. Clinical assessment, physiological monitoring, and continuity remain central.
Epigenetics records responsiveness—not destiny.
WHO | NIH | CDC (2020–2025)
Question for you
How can we use epigenetic insight to improve understanding of placental health without turning adaptive biology into deterministic labels?”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF